Established in 1998, China General Technology (Group) Holding Co Ltd, commonly known as Genertec, is a centrally administered State-owned enterprise, which is directed by the State-owned Assets Supervision and Administration Commission of the State Council (SASAC). It was approved by the government as a pilot enterprise of State-owned capital investment in December 2018.
Supported by more than 87,000 employees, Genertec ran 488 domestic units by the end of July 2021, including 27 industrial sub-groups and secondary level companies, and 91 business branches in overseas markets. It owns 4 listed companies - Shenyang Machine Tool Co Ltd, China Automotive Engineering Research Institute Co Ltd, Genertec Universal Medical Group Co Ltd, and China Meheco Group Co Ltd.
Over the years, Genertec has been focusing on three pillar businesses - advanced manufacturing and technical services, medical and healthcare, trade and engineering services as it mobilizes a strong push for innovation-driven high-quality business development under the optimal organizational structure.
Genertec gained 195.8 billion yuan of sales revenue and 7.83 billion yuan of profit in 2020. It had won the A-level in the performance evaluation of central SOEs for 12 consecutive years (2009-2020), and made the Fortune Global 500 list seven times since 2014.
In the field of advanced manufacturing and technical services, Genertec has taken an active role in serving the national strategy for upgrading the country's manufacturing sector and positioned the development of high-end CNC machine tools as its core business. Since the founding of the People’s Republic of China, the group has produced dozens of national firsts in the field of machine tools, and 20 workers have been honored as role model of the nation, a testament to the group's dedication and commitment as exemplified by Ma Hengchang Team.
At present, Genertec owns one machine tool engineering research institute and six machine tool production and manufacturing companies, and has established machine tool technical innovation strategic alliances.
In addition to holding the largest variety of products and the broadest service areas in the domestic market, the group has the strongest technical capabilities across China, providing the most high-end core equipment and solutions for key industries and areas. It has been vigorously promoting the industrialization of new solvent-based cellulose fiber, making China the second country in the world to master the technology in the industrialization of green cellulose fiber. Its production now reaches the biggest amount in China and takes the second place in the global market.
Genertec's strong inspection and supervision capabilities allow it to successfully launch an early warning platform for the safety of national-standard new energy vehicles, establish a vehicle standard innovation center (Chongqing) in the national standard innovation base, and facilitate the building of a national hydrogen quality supervision and inspection center.
In the field of medical and healthcare industry, the group has strongly championed the Healthy China 2030 strategy by leveraging the strength in its wide-ranging, broad-span, complete-scenario medical resource system to built a robust presence across the healthcare ecosystem that relies on medical service and covers a complete service chain, including pharmaceutical supply chain, health management, health elderly care, rehabilitation care, financial service and other fields.
Currently, Genertec has more than 170 medical institutions with a total of 32,000 beds, its annual number of outpatient and emergency treatments exceeds 16 million in 21 provinces, autonomous regions and municipalities across China. Genertec, as a central SOE, has developed itself into a medical group with leading number of beds, complete network coverage and comprehensive industrial chain.
In the field of trade and engineering services, Genertec is the main channel and a major force for the imports of advanced technology and key equipment in China. Its introduction of 156 advanced technologies and full equipment in the early years of the People's Republic of China laid a solid foundation for the country to develop manufacturing business.
Over the past 70 years, it has imported and introduced more than $340 billion of state-of-the-art technologies and complete sets of equipment for various industries, making a significant contribution to the nation's progress toward industrialization and the localization of major technical equipment.
Genertec’s vigorous participation in the tangible growth of the Belt and Road Initiative has also driven and promoted Chinese standards, technologies and equipment to many parts of the world. It was ranked 67th on ENR's list of the Top 250 International Contractors 2021. The group has won a total of 87 national-level awards in the construction industry, including the China Construction Engineering Luban Prize and the National Quality Engineering Awards, in recognition of its rich history and track record of performance in participation of significantly important construction projects across China.
As a comprehensive service provider for the supply chain of mobile communication terminal products, Genertec is also a leader in the field of terminal product distribution of mobile communication for many years.
Moving forward, Genertec will continuously pursue its mission to create a better life through technological progress and high quality customer service, while living its core values of integrity, inclusiveness, innovation, dedication, excellence, and win-win cooperation. Genertec is committed to becoming a world-class enterprise that is highly competitive on the global stage.